Skip to main content
TECH logo

Bio-Techne Corporation

TECHNASDAQHealthcareBiotechnology

$72.57Today:- (-)1Y +17.23%

As of Oct 16, 2026 close

Market cap
$11.39B
P/E (TTM)
62.61
Forward P/E
31.27
Dividend yield
1.45%
52-week range
$43.20$72.69
Volume (live)
-
Avg. volume (3M)
2.98M

Bio-Techne (TECH) Financial Ratios

For fiscal 2026 (fiscal year ended Jun 30, 2026), Bio-Techne had a P/E ratio of 60.54 (down from 109.94), return on equity of 9.0% (up from 3.7%), debt-to-equity of 0.14 (down from 0.23) and a current ratio of 4.55 (up from 3.46). A current ratio of 4.55 means current assets exceed current liabilities. Its dividend yield was 0.45% with a payout ratio of 27.5%.

Bio-Techne Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Period endingJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Valuation Ratios
P/E Ratio60.54109.9467.1845.0650.01129.39
Forward P/E35.2625.7436.7236.5739.5561.93
P/S Ratio9.066.619.7411.3112.3018.84
P/B Ratio5.224.205.466.548.0011.22
Price/Tangible Book13.2714.0919.1722.9839.06175.38
Price/FCF41.8331.4447.8259.4648.5156.98
Price/OCF37.6928.0537.7750.5241.8149.81
PEG Ratio7.402.396.483.102.472.90
Enterprise Value Ratios
EV/Revenue9.126.8410.0411.5912.3919.05
EV/EBITDA33.1828.8637.1038.2740.3454.57
EV/EBIT40.3837.3746.8246.8449.0874.75
EV/FCF42.1132.5449.3060.9248.8557.62
Profitability & Returns
Return on Equity (ROE)9.03%3.68%8.33%15.57%16.08%9.46%
Return on Assets (ROA)6.67%5.31%5.82%7.12%7.65%10.42%
Return on Invested Capital (ROIC)9.58%7.34%9.89%11.85%13.73%13.53%
Return on Capital Employed (ROCE)11.30%9.40%9.80%11.20%13.20%11.77%
Leverage & Solvency Ratios
Debt/Equity0.140.230.200.230.190.25
Debt/EBITDA0.811.421.251.250.911.29
Debt/FCF1.101.731.782.101.161.37
Liquidity Ratios
Current Ratio4.553.463.874.843.443.35
Quick Ratio2.942.102.473.292.512.48
Efficiency Ratios
Asset Turnover0.470.460.430.460.480.43
Inventory Turnover2.132.212.192.342.692.71
Yield & Distribution Ratios
Earnings Yield1.65%0.91%1.49%2.22%2.00%0.77%
FCF Yield2.39%3.18%2.09%1.68%2.06%1.76%
Dividend Yield0.45%0.63%0.45%0.40%0.38%0.28%
Payout Ratio27.45%68.65%29.99%17.63%18.45%35.34%
Buyback Yield1.70%0.66%0.67%1.38%-1.35%-2.75%
Total Return2.15%1.28%1.12%1.77%-0.97%-2.46%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bio-Techne Financial Ratios

What is Bio-Techne's P/E ratio?

Bio-Techne's P/E ratio was 60.54 for fiscal 2026 (period ended Jun 30, 2026). It was 109.94 a year earlier.

What is Bio-Techne's return on equity?

Bio-Techne's return on equity (ROE) was 9.0% for fiscal 2026 (period ended Jun 30, 2026). It was 3.7% a year earlier.

What is Bio-Techne's debt-to-equity ratio?

Bio-Techne's debt-to-equity ratio was 0.14 for fiscal 2026 (period ended Jun 30, 2026). It was 0.23 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition